MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-19-2026
DarioHealth Corp. Cash Conversion Cycle 2011-2026 | DRIO
Annual Cash Conversion Cycle DarioHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115 | 128 | 207 | 119 | 23 | 68.6 | 16.6 | -66.1 | -32.5 | -62.5 | -72.2 | 160 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 207 | -72.2 | 50.4 |
Quarterly Cash Conversion Cycle DarioHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105 | 108 | 111 | - | 122 | 139 | 151 | - | 247 | 162 | 184 | - | 156 | 135 | 85.7 | - | 34.4 | 48.5 | 39.8 | - | -5.89 | -8.49 | -0.26 | - | 10.6 | 20.5 | -21.9 | - | -69.2 | -63.6 | -59 | - | -36.8 | -50.4 | 12.8 | - | -101 | -71.2 | -47.1 | - | -84.7 | -77.4 | -51.7 | - | -73.9 | -71.5 | -115 | - | - | - | -147 | - | -84.1 | -124 | -70.8 | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 247 | -147 | 10.9 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioNano Genomics
BNGO
|
166 | $ 1.14 | 0.44 % | $ 6.21 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
149 | $ 16.07 | 1.39 % | $ 173 M |  China |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
111 | $ 115.09 | 0.03 % | $ 35 B | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 2.25 | -2.17 % | $ 9.95 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 16.32 | 1.65 % | $ 870 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 498.22 | 0.95 % | $ 14.4 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.45 | 2.3 % | $ 412 M | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 7.87 | 2.34 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 1.4 | 2.19 % | $ 1.86 M | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
45.9 | $ 23.05 | -0.35 % | $ 640 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
36.1 | $ 6.62 | -0.9 % | $ 276 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 176.51 | 0.49 % | $ 8.75 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
-398 | $ 52.58 | -0.1 % | $ 2.67 B | USA |
 |
Danaher Corporation
DHR
|
77.5 | $ 190.99 | 0.73 % | $ 136 B | USA |
 |
Neuronetics
STIM
|
17.3 | $ 1.37 | 1.11 % | $ 90.4 M | USA |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
142 | $ 122.69 | 1.46 % | $ 19.5 B | USA |
 |
Fulgent Genetics
FLGT
|
42.4 | $ 14.96 | 3.67 % | $ 452 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 500.25 | 0.83 % | $ 189 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.69 | -3.28 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
79.6 | $ 79.27 | 0.85 % | $ 9.94 B | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 48.44 | 1.11 % | $ 2.9 B | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.73 | 1.49 % | $ 88.6 K | USA |
 |
Biomerica
BMRA
|
172 | $ 2.1 | -2.1 % | $ 4.82 M | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 28.26 | -0.18 % | $ 20 B | Niderland |
 |
ICON Public Limited Company
ICLR
|
62 | $ 107.45 | 0.59 % | $ 8.86 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 261.12 | 0.07 % | $ 21.7 B | USA |
 |
Natera
NTRA
|
81.5 | $ 197.55 | 2.34 % | $ 19.4 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 80.41 | -0.23 % | $ 5.43 B | USA |
 |
Waters Corporation
WAT
|
731 | $ 318.26 | -0.54 % | $ 19 B | USA |